Michelle Mitchell

• Policy & Insight

COVID-19: “We’re having to rebuild and adapt because of coronavirus”

We’re having to scale down our work to reflect our new situation, but our ambition remains the same, writes our chief executive, Michelle Mitchell. We’re having to scale down our work to reflect our new situation, but our ambition remains the same, writes our chief executive, Michelle Mitchell.

15 July 2020

• Policy & Insight

Opinion: ‘UK cancer research could be set back years by COVID-19. We must act now’

Because of COVID-19 and the devastating impact it’s had on our income, we could be forced to cut £150 million per year from our research funding.  Because of COVID-19 and the devastating impact it’s had on our income, we could be forced to cut £150 million per year from our research funding. 

24 June 2020

• Policy & Insight

Opinion: ‘Medical research charities are falling through the cracks of COVID-19 Government support’

Without specific and strategic Government support, the COVID-19 pandemic could have a deep and long-lasting effect on our work. Without specific and strategic Government support, the COVID-19 pandemic could have a deep and long-lasting effect on our work.

16 June 2020

• Policy & Insight

Our work saves lives – that must mean Black lives too

Like so many of us right now, I’ve been thinking hard about how to be a better ally, writes our CEO, Michelle Mitchell. Like so many of us right now, I’ve been thinking hard about how to be a better ally, writes our CEO, Michelle Mitchell.

12 June 2020

• Policy & Insight

Opinion: ‘Building an NHS workforce for the future must be Boris Johnson’s top health priority’

With a new Prime Minister in office, the Government's commitments to supporting the NHS and building on the strength of science in the UK must become reality. With a new Prime Minister in office, the Government's commitments to supporting the NHS and building on the strength of science in the UK must become reality.

31 July 2019

• Policy & Insight

Opinion: 'New brain tumour research projects reflect Tessa Jowell’s legacy'

'The word ‘legacy’ is often overused, but not about the late Baroness Tessa Jowell'. Michelle Mitchell reflects on Cancer Research UK's new brain tumour funding. 'The word ‘legacy’ is often overused, but not about the late Baroness Tessa Jowell'. Michelle Mitchell reflects on Cancer Research UK's new brain tumour funding.

20 June 2019